Abstract
Coronary heart disease (CHD) is a term that conventionally refers to atheromatous disease of the coronary arteries and the sequelae that result thereof. The focus of this chapter will concentrate on this specific entity in the elderly and its principal complication—acute myocardial infarction. CHD is not a disorder of old age. Indeed, we know that atherosclerotic lesions can be seen as early as the second and third decade. In susceptible individuals, CHD begins even earlier and can be clinically manifest as early as the first decade. This disease process, however, progresses through life so that in the elderly, very marked changes may be observed not only in the coronary arteries but also in all the other major arteries. CHD produces its most devastating consequences in the fourth, fifth, and sixth decades, and at one time it was thought that those who survived that period had escaped its life-limiting or lethal consequences. However, it is now clear that this is not the case since CHD is also a major cause of morbidity and mortality in the elderly (Figure 8-1). Important distinctions exist in CHD in the elderly, however, as will become evident in the course of this chapter, and these must be borne in mind in the management of these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Medalia LS and White PD. Disease of the aged: Analysis of pathological observations in 1,251 autopsy protocols in old persons. JAMA 149: 1433–1437, 1952.
Kennedy RD, Andrews GR, and Caird FI. Ischaemic heart disease in the elderly. Br Heart J 39 (10): 1121–1127, 1977.
Gordon T, Castelli WP, Hjortland MC, Kannel WB, and Dawber TR. Predicting coronary heart disease in middle-aged and older persons. The Framington study. JAMA 238(6):497499, 1977.
McKeown F. Pathology of the Aged. London: Butterworths, 1965, pp 16–39.
Sarnoff SJ, Braunwald E, Welch GH Jr, Case RB, Stainsby WN, and Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 192: 148–156, 1958.
Malcolm ID, Sniderman A, and Morin JE. Successful coronary artery bypass surgery in an 80year-old man with Prinzmetal’s angina. Can Med Assoc J 119 (7): 749–750, 1978.
Campbell AE, Caird FI, and Jackson TFM. Prevalence of abnormalities of electrocardiogram in old people. Br Heart J 36: 1005–1011, 1974.
Pepine CJ and Conti RC. Calcium blockers in coronary heart disease. Part 1, Modern Concepts of Cardiovascular Disease 50: 61–66, 1981.
Pepine CJ and Conti RC. Calcium blockers in coronary heart disease. Part II. Modern Concepts of Cardiovascular Disease 50: 67–72, 1981.
Dargie HJ, Lynch PG, Krikler DM, Harris L, and Krikler S. Nifedipine and propranolol: A beneficial drug interaction. Am J Med 71: 676–682, 1981.
Report of the unstable angina pectoris study group. Unstable angina pectoris national cooperative study group to compare medical and surgical therapy. Part II. American J Cardiol 42: 839–848, 1978.
Crawford T, Decter CD, and Teare RD. Coronary artery pathology in sudden death from myocardial ischemia: A comparison by age group. Lancet 1: 181–185, 1961.
Rodstein M. Heart disease in the aged. In Rossman I (ed), Clinical Geriatrics. Philadelphia: Harper & Row, 1979, pp 181–203.
Pathy MS. Clinical presentation of myocardial infarction in the elderly. Br Heart J 29: 190, 1967.
Thould AL. Coronary heart diseases in the aged. Br Med J 2: 1089, 1965.
Rodstein M. The characteristics of nonfatal myocardial infarction in the aged. Arch Intern Med 98: 84, 1956.
Williams BO, Bess TB, Semple T, and McGuinnes JB. The elderly in a coronary unit. Br Med J 2 (6033): 451–453, 1976.
Zeman FD and Rodstein M. Cardiac rupture complicating myocardial infarction in the aged. Arch Intern Med 105: 431, 1960.
Abrams DL et al. Ventricular aneurysm. A reappraisal based on a study of sixty-five consecutive autopsied cases. Circulation 27: 164, 1963.
Sampson JJ and Hutchinson JC. Heart failure in myocardial infarction. Prog Cardiovasc Dis 10: 1, 1967.
Bjorck G. The biology of myocardial infarction. Circulation 37: 1071, 1968.
Bjorck G, Sievens J, and Blamquist J. Studies in myocardial infarction in Malmo 1935–1954. Part III. Acta Med Scand 162: 81–97, 1958.
Kannel WB and Gordon T. Evaluation of cardiovascular risk factors in the elderly. The Framingham study. Bull NY Acad Med 54: 573–591, 1978.
Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and re-infarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807, 1981.
B-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 247: 1707–1714, 1982.
Hjalmarson A, Herlitz J, Malek I, et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 2: 823–827, 1981.
Wilhelmsson C, Vedin JA, Wilhelmsen L, Tibblin G, and Werko L. Reduction in mortality after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet 2: 1157 1160, 1974.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Dunn, F.G. (1984). Coronary Heart Disease and Acute Myocardial Infarction. In: Messerli, F.H. (eds) Cardiovascular Disease in the Elderly. Developments in Cardiovascular Medicine, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1815-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1815-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1817-1
Online ISBN: 978-1-4757-1815-7
eBook Packages: Springer Book Archive